Docoh
Loading...

APVO Aptevo Therapeutics

News

From Benzinga Pro
61 Biggest Movers From Yesterday
2 Dec 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers
50 Stocks Moving In Wednesday's Mid-Day Session
1 Dec 21
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers
51 Biggest Movers From Yesterday
30 Nov 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers
12 Health Care Stocks Moving In Monday's Intraday Session
29 Nov 21
Intraday Update, Markets, Movers
33 Stocks Moving In Monday's Mid-Day Session
29 Nov 21
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers Krystal Biotech, Inc. (NASDAQ: KRYS) shares jumped 116.4% to $86.13 after the company announced positive topline results from the GEM-3 Phase 3 trial of investigational beremagene geperpavec (B-VEC, Vyjuvek) for dystrophic Epidermolysis Bullosa (dystrophic EB).
12 Health Care Stocks Moving In Monday's Pre-Market Session
29 Nov 21
Movers
56 Biggest Movers From Friday
29 Nov 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers
48 Stocks Moving In Friday's Mid-Day Session
26 Nov 21
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers Allied Healthcare Products, Inc. (NASDAQ: AHPI) shares jumped 68% to $9.04. Shares of mask and protective apparel companies, including Allied Healthcare Products, traded higher amid concerns of a new COVID variant discovered in South Africa.
25 Stocks Moving in Friday's Pre-Market Session
26 Nov 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers
68 Biggest Movers From Wednesday
26 Nov 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) shares gained 689.4% to settle at $78.94 on Wednesday after the company priced its IPO at $10 per share.
12 Health Care Stocks Moving In Wednesday's After-Market Session
24 Nov 21
Movers
Gainers
12 Health Care Stocks Moving In Wednesday's Intraday Session
24 Nov 21
Movers
Gainers Biofrontera (NASDAQ:BFRI) shares increased by 160.83% to $6.86 during Wednesday's regular session. The company's market cap stands at $79.5 million.
40 Stocks Moving In Wednesday's Mid-Day Session
24 Nov 21
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers Biofrontera Inc. (NASDAQ: BFRI) shares jumped 109.5% to $5.51 after Roth Capital initiated coverage on the stock with a Buy rating and a $20 price target.
Benzinga Pro's Top 5 Stocks To Watch For Wednesday, Nov. 24, 2021: KTTA, APVO, TSLA, BFRI, OCUP
24 Nov 21
Pre-Market Outlook
Today's 5 Stock Ideas (Most-Searched Tickers Edition): The list shared below today is the top 5 most-searched tickers in Benzinga Pro over the last 24 hours: Pasithea Therapeutics (KTTA) Aptevo
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
24 Nov 21
Pre-Market Outlook, Markets, Movers
28 Stocks Moving in Wednesday's Pre-Market Session
24 Nov 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Engine Gaming and Media, Inc. (NASDAQ: GAME) rose 51% to $4.80 in pre-market trading after the company reported Q4 2021 and FY21 revenue was higher year over year.
56 Biggest Movers From Yesterday
24 Nov 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Aptevo Therapeutics Inc. (NASDAQ: APVO) shares jumped 162.8% to close at $17.03 after the company announced a clinical update for its Phase 1b Expansion trial evaluating APVO436 for acute myeloid leukemia (AML).
12 Health Care Stocks Moving In Tuesday's After-Market Session
23 Nov 21
Movers
Gainers
Mid-Afternoon Market Update: Dow Surges 100 Points; Zoom Video Shares Plunge
23 Nov 21
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets
Toward the end of trading Tuesday, the Dow traded up 0.29% to 35,723.97 while the NASDAQ fell 1.28% to 15,651.92. The S&P also fell, dropping 0.27% to 4,670.49.
12 Health Care Stocks Moving In Tuesday's Intraday Session
23 Nov 21
Movers
Gainers Pasithea Therapeutics (NASDAQ:KTTA) stock moved upwards by 228.5% to $7.26 during Tuesday's regular session. The company's market cap stands at $95.8 million.

Press releases

From Benzinga Pro
Thinking about buying stock in Palatin Technologies, ContextLogic, Nordstrom, Aptevo Therapeutics, or BioNano Genomics?
24 Nov 21
Opinion, Press Releases
NEW YORK, Nov. 24, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PTN, WISH, JWN, APVO, and BNGO.
Thinking about buying stock in Aptevo Therapeutics, Navitas Semiconductor, Berkshire Grey, Aadi Bioscience, or Emergent Biosolutions?
23 Nov 21
Opinion, Press Releases
NEW YORK, Nov. 23, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for APVO, NVTS, BGRY, AADI, and EBS.
Aptevo Therapeutics Reports First Complete Remission, Providing Clinical Update for Its Phase 1b Multi Center, Multi Cohort Expansion Trial in the Treatment of Acute Myeloid Leukemia
23 Nov 21
News, Press Releases
SEATTLE, WA / ACCESSWIRE / November 23, 2021 / Aptevo Therapeutics Inc. ("Aptevo" or the "Company") (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immuno-oncology
Aptevo Therapeutics Announces the Presentation of Two Abstracts at the Upcoming American Society of Hematology Annual Meeting
15 Nov 21
Events, Press Releases
SEATTLE, WA / ACCESSWIRE / November 15, 2021 / Aptevo Therapeutics Inc. ("Aptevo" or the "Company") (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immuno-oncology
Aptevo Therapeutics Reports Third Quarter Financial Results With Business Highlights
12 Nov 21
Earnings, Press Releases
SEATTLE, WA / ACCESSWIRE / November 12, 2021 / Aptevo Therapeutics Inc. ("Aptevo" or the "Company") (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immuno-oncology
Alligator Bioscience and Aptevo Therapeutics Announce a Poster Presentation of ALG.APV-527 at SITC Annual Meeting 2021
11 Nov 21
News, Press Releases
Data support Advancement into the ClinicLUND, SWEDEN, and SEATTLE, WA / ACCESSWIRE / November 11, 2021 / Alligator Bioscience AB ("Alligator") and Aptevo Therapeutics ("Aptevo") today announce
Aptevo Therapeutics Announces Preclinical Data for Bispecific Antibody APVO603 at the Society for Immunology in Cancer Annual Meeting
11 Nov 21
News, Press Releases
Preclinical data demonstrates inhibited tumor cell growth in vitro when paired with a T-cell engager bispecificSEATTLE, WA / ACCESSWIRE / November 11, 2021 / Aptevo Therapeutics Inc. ("Aptevo" or the
Aptevo Therapeutics Presents Promising Clinical Data on Its Lead Leukemia Drug Candidate APVO436 at The Second Virtual Conference on Controversies in Leukemias, Euroleuk2021
27 Oct 21
News, Press Releases
SEATTLE, WA / ACCESSWIRE / October 27, 2021 / Aptevo Therapeutics Inc. ("Aptevo" or "the Company") (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immuno-oncology
Aptevo Therapeutics Reports in the Refereed Medical Journal Cancers That the Risk of Cytokine Release Syndrome Is Low for Blood Cancer Patients Treated With Its Bispecific Antibody APVO436
26 Oct 21
News, Press Releases
SEATTLE, WA / ACCESSWIRE / October 26, 2021 / Aptevo Therapeutics Inc. ("Aptevo" or "the Company") (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immuno-oncology
Aptevo Therapeutics Announces Publication of a Scientific Article in Peer-Reviewed Journal, Frontiers in Aging
28 Sep 21
News, Press Releases
Lead Clinical Candidate, APVO436, Recently Showed Clinical Activity and Acceptable Safety Profile in Adults with Myelodysplastic Syndrome (MDS)Article outlines a new strategy to employ APVO436 for targeting both MDS